These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 22677465)

  • 21. Results from the Survey of Antibiotic Resistance (SOAR) 2016-17 in Ukraine: data based on CLSI, EUCAST (dose-specific) and pharmacokinetic/pharmacodynamic (PK/PD) breakpoints.
    Torumkuney D; Bratus E; Yuvko O; Pertseva T; Morrissey I
    J Antimicrob Chemother; 2020 Apr; 75(Suppl 1):i100-i111. PubMed ID: 32337596
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Results from the Survey of Antibiotic Resistance (SOAR) 2015-17 in Turkey: data based on CLSI, EUCAST (dose-specific) and pharmacokinetic/pharmacodynamic (PK/PD) breakpoints.
    Torumkuney D; Tunger A; Sancak B; Bıçakçıgil A; Altun B; Aktas Z; Kayacan C; Morrissey I
    J Antimicrob Chemother; 2020 Apr; 75(Suppl 1):i88-i99. PubMed ID: 32337598
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Results from the Survey of Antibiotic Resistance (SOAR) 2015-17 in Pakistan: data based on CLSI, EUCAST (dose-specific) and pharmacokinetic/pharmacodynamic (PK/PD) breakpoints.
    Torumkuney D; Anwar S; Nizamuddin S; Malik N; Morrissey I
    J Antimicrob Chemother; 2020 Apr; 75(Suppl 1):i76-i87. PubMed ID: 32337594
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Results from the Survey of Antibiotic Resistance (SOAR) 2011-14 in the Democratic Republic of Congo, Ivory Coast, Republic of Senegal and Kenya.
    Kacou-Ndouba A; Revathi G; Mwathi P; Seck A; Diop A; Kabedi-Bajani MJ; Mwiti W; Anguibi-Pokou MJ; Morrissey I; Torumkuney D
    J Antimicrob Chemother; 2016 May; 71 Suppl 1(Suppl 1):i21-31. PubMed ID: 27048579
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epidemiologic characteristics, serotypes, and antimicrobial susceptibilities of invasive Streptococcus pneumoniae isolates in a nationwide surveillance study in Lebanon.
    Hanna-Wakim R; Chehab H; Mahfouz I; Nassar F; Baroud M; Shehab M; Pimentel G; Wasfy M; House B; Araj G; Matar G; Dbaibo G;
    Vaccine; 2012 Dec; 30 Suppl 6():G11-7. PubMed ID: 23228352
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of new Clinical Laboratory Standards Institute Streptococcus pneumoniae penicillin susceptibility testing breakpoints on reported resistance changes over time.
    Mera RM; Miller LA; Amrine-Madsen H; Sahm DF
    Microb Drug Resist; 2011 Mar; 17(1):47-52. PubMed ID: 21117969
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Results from the Survey of Antibiotic Resistance (SOAR) 2015-17 in Latin America (Argentina, Chile and Costa Rica): data based on CLSI, EUCAST (dose-specific) and pharmacokinetic/pharmacodynamic (PK/PD) breakpoints.
    Torumkuney D; Smayevsky J; Relloso MS; Sucari A; Pennini M; Brilla E; Vilches V; De la Cruz Y; Morrissey I
    J Antimicrob Chemother; 2020 Apr; 75(Suppl 1):i43-i59. PubMed ID: 32337593
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Results from the Survey of Antibiotic Resistance (SOAR) 2014-16 in the Czech Republic.
    Torumkuney D; Zemlickova H; Maruscak M; Morrissey I
    J Antimicrob Chemother; 2018 Apr; 73(suppl_5):v22-v27. PubMed ID: 29659883
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibiotic susceptibility rates of invasive pneumococci before and after the introduction of pneumococcal conjugate vaccination in Germany.
    Imöhl M; Reinert RR; van der Linden M
    Int J Med Microbiol; 2015 Oct; 305(7):776-83. PubMed ID: 26324014
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regional and global antimicrobial susceptibility among isolates of Streptococcus pneumoniae and Haemophilus influenzae collected as part of the Tigecycline Evaluation and Surveillance Trial (T.E.S.T.) from 2009 to 2012 and comparison with previous years of T.E.S.T. (2004-2008).
    Tomic V; Dowzicky MJ
    Ann Clin Microbiol Antimicrob; 2014 Nov; 13():52. PubMed ID: 25376749
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Non-susceptibility trends and serotype coverage by conjugate pneumococcal vaccines in a Tunisian paediatric population: a 10-year study.
    Charfi F; Smaoui H; Kechrid A
    Vaccine; 2012 Dec; 30 Suppl 6():G18-24. PubMed ID: 23228353
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antimicrobial resistance of Streptococcus pneumoniae isolates in Athens, Greece.
    Kanavaki S; Mantadakis E; Karabela S; Anatoliotaki M; Makarona M; Moraitou H; Pefanis A; Samonis G
    Eur J Clin Microbiol Infect Dis; 2005 Oct; 24(10):693-6. PubMed ID: 16261303
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Results from the Survey of Antibiotic Resistance (SOAR) 2009-11 and 2013-14 in China.
    Hu F; Zhu D; Wang F; Morrissey I; Wang J; Torumkuney D
    J Antimicrob Chemother; 2016 May; 71 Suppl 1(Suppl 1):i33-43. PubMed ID: 27048581
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antimicrobial resistance of Streptococcus pneumoniae and Haemophilus influenzae in Sao Paulo, Brazil from 1996 to 2000.
    Koeth LM; Felmingham D; Jacobs MR; Rossi F
    Int J Antimicrob Agents; 2004 Apr; 23(4):356-61. PubMed ID: 15081084
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trends in antimicrobial resistance in 1,968 invasive Streptococcus pneumoniae strains isolated in Spanish hospitals (2001 to 2003): decreasing penicillin resistance in children's isolates.
    Oteo J; Lázaro E; de Abajo FJ; Baquero F; Campos J;
    J Clin Microbiol; 2004 Dec; 42(12):5571-7. PubMed ID: 15583283
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of susceptibility test methods to detect penicillin susceptibility in Streptococcus pneumoniae isolates.
    Mohd Nasir MD; Parasakthi N
    Malays J Pathol; 2004 Jun; 26(1):29-33. PubMed ID: 16190104
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antimicrobial susceptibility testing of invasive isolates of Streptococcus pneumoniae from Canadian patients: the SAVE study, 2011-15.
    Karlowsky JA; Adam HJ; Golden AR; Baxter MR; Nichol KA; Martin I; Demczuk W; Mulvey MR; Gilmour MW; Hoban DJ; Zhanel GG;
    J Antimicrob Chemother; 2018 Jul; 73(suppl_7):vii5-vii11. PubMed ID: 29982570
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rationale for revised penicillin susceptibility breakpoints versus Streptococcus pneumoniae: coping with antimicrobial susceptibility in an era of resistance.
    Weinstein MP; Klugman KP; Jones RN
    Clin Infect Dis; 2009 Jun; 48(11):1596-600. PubMed ID: 19400744
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Trends in antibiotic susceptibility patterns of Streptococcus pneumoniae and Haemophilus influenzae isolates: four years follow up].
    Ilki A; Sağiroğlu P; Elgörmüş N; Söyletir G
    Mikrobiyol Bul; 2010 Apr; 44(2):169-75. PubMed ID: 20549950
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antimicrobial resistance among Streptococcus pneumoniae and Haemophilus influenzae isolates in the United Arab Emirates: 2004-2006.
    Senok A; Al-Zarouni M; Al-Najjar J; Nublusi A; Panigrahi D
    J Infect Dev Ctries; 2007 Dec; 1(3):296-302. PubMed ID: 19734608
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.